UK markets closed
NIKKEI 225
38,073.98 -128.39 (-0.34%) HANG SENG
18,537.81 +223.95 (+1.22%) CRUDE OIL
79.27 +0.28 (+0.35%) GOLD FUTURES
2,340.70 +18.40 (+0.79%) DOW
39,246.73 +190.34 (+0.49%) Bitcoin GBP
49,879.57 +102.25 (+0.21%)
Asahi Kasei Corporation (ASA.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:15AM CEST. Market open.
| Previous close | 12.50 |
| Open | 12.90 |
| Bid | 13.40 x N/A |
| Ask | 13.60 x N/A |
| Day's range | 12.90 - 12.90 |
| 52-week range | 11.10 - 13.40 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 9.42B |
| Beta (5Y monthly) | 0.75 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.85 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | 0.46 (3.68%) |
| Ex-dividend date | 28 Sept 2023 |
| 1y target est | N/A |
Business WireAsahi Kasei Bioprocess to Unveil THESYS™ ACS ERGO Synthesis Column at TIDES USA
TOKYO & NEW YORK & DÜSSELDORF, Germany, May 02, 2024--Asahi Kasei Bioprocess' (AKB) THESYS™ ACS ERGO synthesis column will be on display and demonstrated at Booth 213 at TIDES USA 2024.
Business WireAsahi Kasei to Construct a Lithium-ion Battery Separator Plant in Canada
TOKYO & NEW YORK & DÜSSELDORF, Germany, April 25, 2024--Asahi Kasei plans to construct an integrated plant in Ontario, Canada for base film manufacturing and coating of Hipore™ wet-process LIB separator.
Business WireAsahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development
TOKYO & NEW YORK & DÜSSELDORF, Germany, April 11, 2024--Asahi Kasei Bioprocess (AKB) and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics.
© 2024 Yahoo. All rights reserved.